Futura Medical Expects £1.7mln in 2025 Revenue, Supports Operations Until 2026

Futura Medical has raised its full-year revenue forecast to £1.7mln for 2025, exceeding previous guidance. The company's net cash at year-end was £3.4mln, and it anticipates a tax credit refund of £300,000 and a US$2.5mln milestone payment from Haleon in 2026. The strategic review of the business is set to conclude in Q1 2026, with results to be published alongside full-year figures in mid-April.